Acta Anatomica Sinica ›› 2023, Vol. 54 ›› Issue (5): 538-545.doi: 10.16098/j.issn.0529-1356.2023.05.006

• Cell and Molecules Biology • Previous Articles     Next Articles

Erythrocyte membrane-associated protein inhibiting Th17 cell differentiation via IL-6/STAT3/ROR-γt signaling pathway in experimental autoimmune encephalomyelitis mice encephalomyelitis mice

HE  Ke-ke1  LI  Yuan-di1  WEN  Ting-hao1  ZHU  Jie1  GAO  Jie1,3 HU  Rong1,3  HAN  Feng4  SU  Min1,2*    

  1. 1. Department of Histology and Embryology, Basic Medical College, Guizhou Medical University, Guiyang 550025, China;
    2.National Joint Local Engineering Laboratory for Cell Engineering and Biomedicine Technique, Guizhou Province Key 
    Laboratory of Regenerative Medicine, Key Laboratory of Adult Stem Cell Translational Research(Chinese Academy of Medical Sciences), Guizhou Medical University,  Guiyang 55025, China;  3.Translational Medicine Research Center, Guizhou Medical University, Guiyang 55025, China;   4.Department of Neurosurgery, the Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China
  • Received:2022-12-29 Revised:2023-03-16 Online:2023-10-06 Published:2023-12-25

Abstract:

 Objective  To explore the effect of exogenous and endogenous erythrocyte membrane-associated protein (ERMAP) on helper T cell 17(Th17) cell differentiation through interleukin 6/signal transducers and activators of transcription 3/retionoid-related orphan nuclear receptor-γt(IL-6/STAT3/ROR-γt) signal pathway in the mouse model of experimental autoimmune encephalomyelitis (EAE).    Methods  Using flow cytometry to verify the function of ERMAP-Ig fusion protein at different concentrations; Agarose gel electrophoresis was performed to identify ERMAP knockout mice. Flow cytometry was performed to detect the effect of ERMAP-Ig fusion protein on Th17 cell differentiation in vitro. Forty 6-week-old normal C57BL/6 mice were randomly divided into 2 groups to establish EAE models, control-Ig and ERMAP-Ig groups, with 20 mice in each group; Clinical scores were recorded; Flow cytometry was performed to detect Th17 cell differentiation in EAE mice in vivo. Forty 6-week-old identified wild-type and ERMAP knockout mice were divided into 2 groups to establish EAE models. Identified wild-type and ERMAP knockout mice were divided into 2 groups to establish EAE models, ERMAP+/+ and ERMAP-/- groups, with 20 mice in each group. Clinical scores were recorded; Spinal cord HE and luxol fast blue(LFB) staining and histological semi-quantitative scoring were performed. Flow cytometry was performed to detect the percentage of IL-17A+CD4+ T cells; Western blotting was performed to detect the expression of IL-6, IL-17, STAT3, p-STAT3, and ROR-γt protein levels; Real-time PCR was performed to detect the mRNA expression of IL-17, TNF-α, IL-6, STAT3, and ROR-γt; ELISA was performed to detect the expression of IL-17 and TNF-α at the cellular level was detected by ELISA.    Results  1. Exogenous ERMAP-Ig fusion protein inhibited Th17 cell differentiation and attenuated EAE symptoms in mice. 2. Compared with the control group, ERMAP-/- EAE mice showed increased inflammation and demyelination symptoms and increased Th17 secretion of IL-17A. 3. Endogenous ERMAP knockdown resulted in increased expression of IL-17, TNF-α, IL-6 STAT3, and ROR-γt. All differences were statistically significant(P<0.05).    Conclusion  ERMAP may regulate Th17 cell differentiation through the IL-6/STAT3/ROR-γt signaling pathway and is involved in the development of EAE in mice.

Key words:

CLC Number: